Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients-Reference-Cited by-同舟云学术

Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients

Published:2020-01-06 Issue:5 Volume:61 Page:1238-1241
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dalla Palma Benedetta¹²,Accardi Fabrizio¹²,Prezioso Lucia²,Notarfranchi Laura¹²,Giuliani Nicola¹²^ORCID

Affiliation:

1. Department of Medicine and Surgery, University of Parma, Parma, Italy;

2. Hematology and BMT Unit, “Azienda Ospedaliero-Universitaria di Parma”, Parma, Italy

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1706735

Reference16 articles.

1. From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

2. Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial

3. High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

4. The role of complete response in multiple myeloma

5. Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in Conditioning Regimen for Autologous Stem Cell Transplantation in Multiple Myeloma;Advances in Clinical Medicine;2023

2. Cdc25C/cdc2/cyclin B, raf/MEK/ERK and PERK/eIF2α/CHOP pathways are involved in forskolin-induced growth inhibition of MM.1S cells by G2/M arrest and mitochondrion-dependent apoptosis;Cell Cycle;2021-10-04